Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary TumorsMatthew J O'Shaughnessy, Katie S Murray, Stephen P La Rosa, et al.
Immunity|January 21, 2016
Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to ExhaustionNicole Malandro, Sadna Budhu, Nicholas F Kuhn, et al.
Communications Biology|November 18, 2021
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancerAditi Gupta, Sadna Budhu, Kelly Fitzgerald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2008
Mechanisms of immunization against cancer using chimeric antigensManuel E Engelhorn, José A Guevara-Patiño, Taha Merghoub, et al.
The Journal of Investigative Dermatology|February 2, 2017
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant MelanomaSebastian Trousil, Shuang Chen, Chan Mu, et al.
Advances in Cancer Research|July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome MalignancyDanny N Khalil, Sadna Budhu, Billel Gasmi, et al.
Cancer Research Communications|November 6, 2023
Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and TrametinibPaul B Chapman, Mark Klang, Michael A Postow, et al.
The Journal of Experimental Medicine|February 17, 2010
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A Quezada, Tyler R Simpson, Karl S Peggs, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2012
EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumorsChristopher H Evans, Fangjun Liu, Ryan M Porter, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary TumorsMatthew J O'Shaughnessy, Katie S Murray, Stephen P La Rosa, et al.
Immunity|January 21, 2016
Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to ExhaustionNicole Malandro, Sadna Budhu, Nicholas F Kuhn, et al.
Communications Biology|November 18, 2021
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancerAditi Gupta, Sadna Budhu, Kelly Fitzgerald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2008
Mechanisms of immunization against cancer using chimeric antigensManuel E Engelhorn, José A Guevara-Patiño, Taha Merghoub, et al.
The Journal of Investigative Dermatology|February 2, 2017
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant MelanomaSebastian Trousil, Shuang Chen, Chan Mu, et al.
Advances in Cancer Research|July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome MalignancyDanny N Khalil, Sadna Budhu, Billel Gasmi, et al.
Cancer Research Communications|November 6, 2023
Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and TrametinibPaul B Chapman, Mark Klang, Michael A Postow, et al.
The Journal of Experimental Medicine|February 17, 2010
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A Quezada, Tyler R Simpson, Karl S Peggs, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2012
EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumorsChristopher H Evans, Fangjun Liu, Ryan M Porter, et al.
Pageof 22